But look what happened to the DNDN after it received FDA approval - same thing will happen to AMRN address RI results are in and after we receive RI indication on label (if there's no BO by then). So if you want to compare, you can only do so until the FDA approval. What happened to DNDN after that is because of their drug - costs what, $100,000 to prolong life a few months while in pain. That's why they went bankrupt.
Not the case with AMRN, V SAVES lives (will be proven so) and costs a fraction of what DNDN's drug costs